These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 27108248)

  • 41. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study.
    Seman LJ; DeLuca C; Jenner JL; Cupples LA; McNamara JR; Wilson PW; Castelli WP; Ordovas JM; Schaefer EJ
    Clin Chem; 1999 Jul; 45(7):1039-46. PubMed ID: 10388480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease].
    Ma Y; Rao J; Long J; Lin L; Liu J; Guo Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):235-240. PubMed ID: 30890514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
    Barra S; Cuomo V; Silvestri N; Materazzi C; Vitagliano G; Capozzi G; Caruso S; Gaeta G; Trevisan M
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):482-6. PubMed ID: 21519277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels - A multicenter observational study.
    Schatz U; Tselmin S; Müller G; Julius U; Hohenstein B; Fischer S; Bornstein SR
    Atheroscler Suppl; 2017 Nov; 30():246-252. PubMed ID: 29096845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance.
    Dahlén GH; Stenlund H
    Clin Genet; 1997 Nov; 52(5):272-80. PubMed ID: 9520117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
    Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
    Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.
    Meeusen JW; Donato LJ; Jaffe AS
    Curr Cardiol Rep; 2017 Jun; 19(6):48. PubMed ID: 28432661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis.
    Valentine RJ; Kaplan HS; Green R; Jacobsen DW; Myers SI; Clagett GP
    J Vasc Surg; 1996 Jan; 23(1):53-61, discussion 61-3. PubMed ID: 8558743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
    Suk Danik J; Rifai N; Buring JE; Ridker PM
    JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Konishi H; Miyauchi K; Shitara J; Endo H; Wada H; Doi S; Naito R; Tsuboi S; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Am J Cardiol; 2016 Dec; 118(12):1781-1785. PubMed ID: 27712648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
    Leebmann J; Roeseler E; Julius U; Heigl F; Spitthoever R; Heutling D; Breitenberger P; Maerz W; Lehmacher W; Heibges A; Klingel R;
    Circulation; 2013 Dec; 128(24):2567-76. PubMed ID: 24056686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoprotein(a) as a potent risk indicator for early cardiovascular disease.
    Dirisamer A; Widhalm K
    Acta Paediatr; 2002; 91(12):1313-7. PubMed ID: 12578287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern.
    von Dryander M; Fischer S; Passauer J; Müller G; Bornstein SR; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):39-44. PubMed ID: 23357139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran.
    Meraji S; Abuja PM; Hayn M; Kostner GM; Morris R; Oraii S; Tatzber F; Wonisch W; Zechner R; Gey KF
    Atherosclerosis; 2000 Jun; 150(2):403-12. PubMed ID: 10856533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart Disease.
    Arnold N; Blaum C; Goßling A; Brunner FJ; Bay B; Zeller T; Ferrario MM; Brambilla P; Cesana G; Leoni V; Palmieri L; Donfrancesco C; Ojeda F; Linneberg A; Söderberg S; Iacoviello L; Gianfagna F; Costanzo S; Sans S; Veronesi G; Thorand B; Peters A; Tunstall-Pedoe H; Kee F; Salomaa V; Schnabel RB; Kuulasmaa K; Blankenberg S; Waldeyer C; Koenig W;
    J Am Coll Cardiol; 2024 Jul; 84(2):165-177. PubMed ID: 38960510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.